Reviving the FDA's Authority to Publicly Explain Why New Drug Applications Are Approved or Rejected

JAMA Intern Med. 2018 Aug 1;178(8):1013-1014. doi: 10.1001/jamainternmed.2018.3137.
No abstract available

Publication types

  • Review

MeSH terms

  • Access to Information / legislation & jurisprudence*
  • Civil Rights / legislation & jurisprudence
  • Drug Approval / legislation & jurisprudence*
  • Humans
  • Product Recalls and Withdrawals / legislation & jurisprudence*
  • Product Surveillance, Postmarketing / standards*
  • United States
  • United States Food and Drug Administration / legislation & jurisprudence*